Transition to a Direct Sales and Service Structure through a Local Subsidiary in Saudi Arabia
First written in FY2022. 2 of 3 entries say "Advanced", first in FY2024. Latest entry: FY2025-H1.
No other company in this theme has enough history to compare yet.
- FY2025-H1AdvancedAnnual report
「The effect of the change to direct sales in Saudi Arabia also contributed to increases in sales of hematology instruments and reagents and of reagents in the blood coagulation testing field.」
The company disclosed in its first-half results that the change to direct sales in Saudi Arabia contributed to increased sales of hematology instruments and reagents and of reagents in the blood coagulation testing field. - FY2024AdvancedAnnual report
「The effect of the change to direct sales in Saudi Arabia also contributed to increases in sales of instruments, reagents and maintenance services in the hematology field.」
The company disclosed that the change to direct sales in Saudi Arabia contributed to increased sales of hematology instruments, reagents and maintenance services. - FY2022First statedAnnual report
「In Saudi Arabia, where strong market growth is expected within the Middle East, the company established a new local subsidiary to further strengthen its business platform. By changing from activities through local distributors to a direct sales and service system, the company will accurately identify customer needs, further expand its share in the core hematology field, acquire market share in urinalysis and blood coagulation testing, and expand into other businesses.」
The company described a new regional expansion initiative involving the establishment of a local subsidiary in Saudi Arabia and a change from sales through distributors to a direct sales and service system.